Specifically, the Tudor domain of KDM4A competes with the binding site of 53BP1 on H4K20me2 and abrogates 53BP1 recruitment to DNA damage sites, which leads to genomic integrity in CRC cells. This evidence concerns the gene TP53BP1 and colorectal carcinoma.